Darnieder, L. M.
Melón, L. C. http://orcid.org/0000-0002-2256-3707
Do, T.
Walton, N. L.
Miczek, K. A.
Maguire, J. L. http://orcid.org/0000-0002-4085-8605
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (AA013983, R01AA026256)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS073574, NS102937, NS047243)
Article History
Received: 28 February 2019
Accepted: 8 May 2019
First Online: 30 May 2019
Competing Interests
: J.M. is a member of the SAGE Therapeutics Scientific Advisory Board, receives funding from SAGE Therapeutics through a Sponsored Research Agreement, and has stocks in SAGE Therapeutics. L.D., L.M., T.D., N.W. and K.M. declare no competing interests.